{"id":4027,"date":"2022-10-12T18:58:46","date_gmt":"2022-10-12T18:58:46","guid":{"rendered":"https:\/\/ramib.org\/oficial\/?p=4027"},"modified":"2022-10-28T17:10:55","modified_gmt":"2022-10-28T17:10:55","slug":"4027","status":"publish","type":"post","link":"https:\/\/ramib.org\/oficial\/index.php\/2022\/10\/12\/4027\/","title":{"rendered":"Sessi\u00f3 acad\u00e8mica de la Acad\u00e8mia M\u00e8dic-Quir\u00fargica Espanyola i la Reial Acad\u00e8mia de Medicina de les Illes Balears"},"content":{"rendered":"\n<p>Dimarts passat 18 d&#8217;octubre de 2022 l&#8217;Acad\u00e8mia M\u00e8dic-Quir\u00fargica Espanyola (AMQE) i la Reial Acad\u00e8mia de Medicina de les Illes Balears (RAMIB) van dur a terme una sessi\u00f3 cient\u00edfica dedicada a la posada al dia de les tres patologies oncol\u00f2giques m\u00e9s freq\u00fcents.<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib1.jpg\" alt=\"\" class=\"wp-image-4072\" srcset=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib1.jpg 1024w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib1-300x200.jpg 300w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib1-768x512.jpg 768w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib1-696x464.jpg 696w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib1-630x420.jpg 630w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n\n\n<p>Va obrir l&#8217;acte el president de la RAMIB, Dr. Joan Besalduch Vidal i el president de la AMQE, Dr. Luis Ortiz Quintana.<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib0.jpg\" alt=\"\" class=\"wp-image-4074\" srcset=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib0.jpg 1024w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib0-300x200.jpg 300w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib0-768x512.jpg 768w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib0-696x464.jpg 696w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib0-630x420.jpg 630w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n\n\n<p>El M. Il\u00b7ltre. Sr. Arturo L\u00f3pez Gonz\u00e1lez, vicepresident de la RAMIB, va ser l&#8217;encarregat de moderar la sessi\u00f3 i el posterior col\u00b7loqui a les pon\u00e8ncies.<\/p>\n\n\n\n<p>La primera pon\u00e8ncia va tenir per t\u00edtol Novetats preventiu-terap\u00e8utiques en el c\u00e0ncer de pulm\u00f3 i va ser duta a terme per la Dra. Josefa Terrassa Pons, cap del servei d&#8217;Oncologia M\u00e8dica de Son Espases que porta prop de 40 anys dedicada a tractar el c\u00e0ncer de pulm\u00f3. L&#8217;especialista va recordar que el 18% dels pacients que moren per un tumor oncol\u00f2gic el fan per afectaci\u00f3 del pulm\u00f3. \u00abAix\u00f2 passa perqu\u00e8 diagnostiquem tard\u00bb, va aclarir. Segons la doctora Terrassa, gaireb\u00e9 el 60% dels tumors ja s&#8217;han disseminat en detectar-se, \u00abper la qual cosa el pron\u00f2stic \u00e9s deplorable\u00bb. Com canviar-ho? D&#8217;una banda amb la prevenci\u00f3 prim\u00e0ria, \u00abentre un 85 i un 90% dels casos es deuen al tabac, si deixem de fumar baixa la incid\u00e8ncia\u00bb, va assenyalar. No obstant aix\u00f2, malgrat mostrar-se a favor d&#8217;arribar fins i tot a multar al fumador, l&#8217;h\u00e0bit roman i cal buscar altres maneres de prevenci\u00f3. La doctora Terrassa \u00e9s partid\u00e0ria d&#8217;implantar el garbellat amb el TAC de baixa dosi, encara que tamb\u00e9 reconeix que avui dia t\u00e9 molts inconvenients \u00abcom el sobreesfor\u00e7 sanitari, i el cost econ\u00f2mic i hum\u00e0\u00bb que requereix.<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib3.jpg\" alt=\"\" class=\"wp-image-4076\" srcset=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib3.jpg 1024w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib3-300x200.jpg 300w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib3-768x512.jpg 768w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib3-696x464.jpg 696w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib3-630x420.jpg 630w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n\n\n<p>Malgrat tot, tamb\u00e9 va assegurar que les societats cient\u00edfiques intenten posar en marxa el denominat programa Casandra en un futur no lluny\u00e0. Quant a tractaments, va advertir que quan el tumor es detecta en els estadis 1 i 2 cal optar per la cirurgia, \u00abper\u00f2 els percentatges d&#8217;\u00e8xit no s\u00f3n tan elevats a partir de determinades grand\u00e0ries d&#8217;afectaci\u00f3 ganglional\u00bb, va assenyalar. La revoluci\u00f3 en aquest camp va arribar amb l&#8217;entrada del nou segle i l&#8217;estudi molecular, \u00aben menys de 15 anys es van triplicar els avan\u00e7os en el tractament de c\u00e0ncer de pulm\u00f3\u00bb. La doctora Terrassa va destacar la import\u00e0ncia de l&#8217;abordatge multidisciplinari i del paper de la medicina personalitzada o de precisi\u00f3. Abans de finalitzar va parlar del futur que ja \u00e9s present: la bi\u00f2psia l\u00edquida. \u00abFer una seq\u00fcenciaci\u00f3 de material gen\u00f2mic permetr\u00e0 aconseguir avan\u00e7os per al diagn\u00f2stic preco\u00e7. Pot ser que, amb l&#8217;an\u00e0lisi en sang, sapiguem que el pacient desenvolupar\u00e0 o t\u00e9 ja una neopl\u00e0sia\u00bb, va concloure.<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib2.jpg\" alt=\"\" class=\"wp-image-4078\" srcset=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib2.jpg 1024w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib2-300x200.jpg 300w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib2-768x512.jpg 768w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib2-696x464.jpg 696w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib2-630x420.jpg 630w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n\n\n<p>La segona pon\u00e8ncia va portar per t\u00edtol Novetats preventiu-terap\u00e8utiques en el c\u00e0ncer de pr\u00f2stata i va ser duta a terme pel doctor Joan Benejam Gual, acad\u00e8mic numerari de la RAMIB i cap del servei d&#8217;Urologia de l&#8217;Hospital de Manacor, va aprofundir en la situaci\u00f3 del c\u00e0ncer de pr\u00f2stata, \u00abel primer entre els homes i el tercer m\u00e9s letal\u00bb va assenyalar. A m\u00e9s, el 5% dels casos es diagnostica d&#8217;inici amb met\u00e0stasi, \u00abun dels factors pels quals la Comissi\u00f3 Europea ha considerat el garbellat\u00bb, va indicar l&#8217;expert. Amb els anys s&#8217;ha demostrat que per cada 500 pacients que passaven per la prova preventiva se salvava una vida. Segons l&#8217;ur\u00f2leg, al principi es rebutjava el garbellat per un \u00abproblema de sobrediagn\u00f3stico\u00bb, alguna cosa que ara es podria evitar perqu\u00e8 \u00absi usem millor el PSA (una an\u00e0lisi de sang) no cal fer tanta bi\u00f2psia\u00bb, va incidir, i aquesta extracci\u00f3 t\u00e9 un cost de tres euros.<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/ambqeramib4.jpg\" alt=\"\" class=\"wp-image-4080\" srcset=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/ambqeramib4.jpg 1024w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/ambqeramib4-300x200.jpg 300w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/ambqeramib4-768x512.jpg 768w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/ambqeramib4-696x464.jpg 696w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/ambqeramib4-630x420.jpg 630w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n\n\n<p>Pel que fa al c\u00e0ncer de pr\u00f2stata, a difer\u00e8ncia d&#8217;uns altres, \u00abno hi ha un factor de risc que es pugui evitar\u00bb. L&#8217;edat, l&#8217;\u00e8tnia o la hist\u00f2ria familiar, no obstant aix\u00f2, s\u00ed que han de tenir-se en compte. En aquest sentit, es pot ser \u00abestricte\u00bb amb l&#8217;assessorament gen\u00e8tic que no estaria implementat en tota Espanya, ja que \u00abentre el 5 i 10% dels c\u00e0ncer de pr\u00f2stata s\u00f3n hereditaris\u00bb. Pel que fa al tractament, el doctor Benejam va utilitzar un manament. \u00abNo sobretratar\u00e1s\u00bb, i va defensar la import\u00e0ncia de realitzar una vigil\u00e0ncia activa en els pacients amb baix risc per a aix\u00ed \u00abevitar cirurgies, tractaments i sofriment\u00bb.<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib5.jpg\" alt=\"\" class=\"wp-image-4082\" srcset=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib5.jpg 1024w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib5-300x200.jpg 300w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib5-768x512.jpg 768w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib5-696x464.jpg 696w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib5-630x420.jpg 630w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n\n\n<p>Per a finalitzar, l&#8217;\u00faltim ponent va ser el coordinador de la Unitat de Cirurgia Oncol\u00f2gica Peritoneal de Son Espases i tamb\u00e9 acad\u00e8mic numerari de la RAMIB, Dr. Rafael Morales Soriano. La seva pon\u00e8ncia Novetats preventiu-terap\u00e8utiques en el c\u00e0ncer de p\u00e0ncrees va tractar el c\u00e0ncer \u00abm\u00e9s dram\u00e0tic\u00bb. En 2020 el p\u00e0ncrees era el tercer tumor amb m\u00e9s mortalitat i abans de 2030 ser\u00e0 el segon \u00abper dues raons: la resist\u00e8ncia al tractament i per la seva progressiva infiltraci\u00f3\u00bb. No obstant aix\u00f2, malgrat haver augmentat la seva incid\u00e8ncia en un 10% en els \u00faltims anys, \u00abhi ha m\u00e9s superviv\u00e8ncia, millors cures postoperat\u00f2ries, a m\u00e9s d&#8217;un concepte nou de quimioter\u00e0pia\u00bb, va assenyalar l&#8217;especialista.<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib6.jpg\" alt=\"\" class=\"wp-image-4084\" srcset=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib6.jpg 1024w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib6-300x200.jpg 300w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib6-768x512.jpg 768w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib6-696x464.jpg 696w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib6-630x420.jpg 630w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib7.jpg\" alt=\"\" class=\"wp-image-4086\" srcset=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib7.jpg 1024w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib7-300x200.jpg 300w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib7-768x512.jpg 768w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib7-696x464.jpg 696w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib7-630x420.jpg 630w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>Les pon\u00e8ncies furs seguides amb gran inter\u00e8s pel p\u00fablic assistent i una vegada finalitzades es va dur a terme l&#8217;habitual col\u00b7loqui entre el p\u00fablic assistent i els ponents.<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib11.jpg\" alt=\"\" class=\"wp-image-4088\" srcset=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib11.jpg 1024w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib11-300x200.jpg 300w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib11-768x512.jpg 768w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib11-696x464.jpg 696w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib11-630x420.jpg 630w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib9.jpg\" alt=\"\" class=\"wp-image-4090\" srcset=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib9.jpg 1024w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib9-300x169.jpg 300w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib9-768x432.jpg 768w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib9-696x392.jpg 696w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2022\/10\/amqeramib9-747x420.jpg 747w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><figcaption>El Dr. Luis Ortiz, president de l&#8217;AMQE signant el llibre d&#8217;honor de la RAMIB<\/figcaption><\/figure><\/div>\n\n\n\n<p>Poden visualitzar les pon\u00e8ncies en el canal de youtube de la corporaci\u00f3 clicant en el seg\u00fcent enlla\u00e7:<\/p>\n\n\n\n<figure class=\"wp-block-embed aligncenter is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"Sesi\u00f3n de la Academia M\u00e9dico-Quir\u00fargica Espa\u00f1ola y la Real Academia de Medicina de Islas Baleares\" width=\"696\" height=\"392\" src=\"https:\/\/www.youtube.com\/embed\/3AQXprrhfgY?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Dimarts passat 18 d&#8217;octubre de 2022 l&#8217;Acad\u00e8mia M\u00e8dic-Quir\u00fargica Espanyola (AMQE) i la Reial Acad\u00e8mia de Medicina de les Illes Balears (RAMIB) van dur a terme una sessi\u00f3 cient\u00edfica dedicada a [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":4092,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[24,269,17],"tags":[352,280,363,362,199],"_links":{"self":[{"href":"https:\/\/ramib.org\/oficial\/index.php\/wp-json\/wp\/v2\/posts\/4027"}],"collection":[{"href":"https:\/\/ramib.org\/oficial\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ramib.org\/oficial\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ramib.org\/oficial\/index.php\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ramib.org\/oficial\/index.php\/wp-json\/wp\/v2\/comments?post=4027"}],"version-history":[{"count":2,"href":"https:\/\/ramib.org\/oficial\/index.php\/wp-json\/wp\/v2\/posts\/4027\/revisions"}],"predecessor-version":[{"id":4095,"href":"https:\/\/ramib.org\/oficial\/index.php\/wp-json\/wp\/v2\/posts\/4027\/revisions\/4095"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ramib.org\/oficial\/index.php\/wp-json\/wp\/v2\/media\/4092"}],"wp:attachment":[{"href":"https:\/\/ramib.org\/oficial\/index.php\/wp-json\/wp\/v2\/media?parent=4027"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ramib.org\/oficial\/index.php\/wp-json\/wp\/v2\/categories?post=4027"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ramib.org\/oficial\/index.php\/wp-json\/wp\/v2\/tags?post=4027"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}